2022_Oct_PODD_Boston_ Skyscraper2

ORALLY INHALED & NASAL DRUG PRODUCTS

Issue No #22  November 1st, 2010


Download PDF


CONTENTS
Innovation in Drug Delivery by Inhalation
Andrea Leone-Bay, VP, Pharmaceutical Development
Dr Robert Baughman, VP, Clinical Pharmacology & Bioanalytics
Mr Chad Smutney, Senior Director, Device Technology
Mr Joseph Kocinsky, Senior VP, Pharm Tech Dev
MannKind Corporation
Current Innovations in Dry Powder Inhalers
Richard Sitz, Technical Mgr, DPI Tech Platform Leader
3M Drug Delivery Systems
Pulmonary Delivery & Dry-Powder Inhalers: Advances in Hard-Capsule Technology
Mr Brian Jones, Scientific Advisor
Mr Fernando Díez, Business Development Manager
Qualicaps Europe, SAU
Pulsating Aerosols for Sinus Drug Delivery: New Treatment Options & Perspectives in Chronic Rhinosinusitis
Dr Manfred Keller, Executive Vice-President and CSO
Uwe Schuschnig, Senior Manager, Aerosol Characterisation
Dr Winfried Moeller, Senior Scientist, iLBD, Helmholtz Zentrum
PARI Pharma GmbH
Simulating Delivery of Pulmonary (and Intranasal) Aerosolised Drugs
Dr Siladitya Ray Chaudhuri, Senior Scientist
Dr Viera Lukacova, Team Leader, Simulation Technologies
Simulations Plus, Inc
Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery
Mr Richard Turner, Business Development Director
Presspart Manufacturing Ltd
Top